StockMacro
Company, fund or insider

Help

Menu

ARS Pharmaceuticals

SPRY on XNAS, ARS Pharmaceuticals, Inc.

Measures activity, not value. Not investment advice.

Window

What usually follows Federal contracts growth was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it

No federal contracts data for ARS Pharmaceuticals.

For context, the picture for its sector (Health Care) is below.

Health Care: Federal obligations: $177.3M in July 2026, 1.3× the 3-year median

USAspending.gov obligations by date. All Health Care companies we match.